Janna C. Collins

1.2k total citations
24 papers, 867 citations indexed

About

Janna C. Collins is a scholar working on Molecular Biology, Clinical Biochemistry and Nutrition and Dietetics. According to data from OpenAlex, Janna C. Collins has authored 24 papers receiving a total of 867 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Clinical Biochemistry and 6 papers in Nutrition and Dietetics. Recurrent topics in Janna C. Collins's work include Metabolism and Genetic Disorders (10 papers), Peroxisome Proliferator-Activated Receptors (10 papers) and Amino Acid Enzymes and Metabolism (3 papers). Janna C. Collins is often cited by papers focused on Metabolism and Genetic Disorders (10 papers), Peroxisome Proliferator-Activated Receptors (10 papers) and Amino Acid Enzymes and Metabolism (3 papers). Janna C. Collins collaborates with scholars based in United States, France and Netherlands. Janna C. Collins's co-authors include Richard J. Stockert, Sidney Goldfischer, A Morell, Irmin Sternlieb, Isabelle Rapin, J. M. Tager, Anatol G. Morell, R. B. H. Schutgens, A. W. Schram and Takashi Hashimoto and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Janna C. Collins

24 papers receiving 842 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janna C. Collins United States 12 566 296 136 104 98 24 867
Kayoko Sudo Japan 14 345 0.6× 110 0.4× 105 0.8× 62 0.6× 17 0.2× 35 666
Tomoyuki Yamasaki Japan 15 564 1.0× 90 0.3× 145 1.1× 92 0.9× 10 0.1× 36 899
D G Brocks Germany 10 359 0.6× 194 0.7× 205 1.5× 30 0.3× 14 0.1× 15 637
Yoji Shibayama United States 13 183 0.3× 78 0.3× 75 0.6× 32 0.3× 12 0.1× 23 818
Esmeralda Martins Portugal 20 484 0.9× 495 1.7× 226 1.7× 50 0.5× 9 0.1× 77 988
M F Melhem United States 13 332 0.6× 49 0.2× 24 0.2× 280 2.7× 44 0.4× 22 731
Kunihiko Tatsumi Japan 8 296 0.5× 63 0.2× 28 0.2× 282 2.7× 18 0.2× 8 663
Elisa Oppici Italy 20 676 1.2× 144 0.5× 43 0.3× 123 1.2× 13 0.1× 28 930
Richard L. Boriack United States 17 536 0.9× 230 0.8× 184 1.4× 47 0.5× 14 0.1× 32 828

Countries citing papers authored by Janna C. Collins

Since Specialization
Citations

This map shows the geographic impact of Janna C. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janna C. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janna C. Collins more than expected).

Fields of papers citing papers by Janna C. Collins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janna C. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janna C. Collins. The network helps show where Janna C. Collins may publish in the future.

Co-authorship network of co-authors of Janna C. Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Janna C. Collins. A scholar is included among the top collaborators of Janna C. Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janna C. Collins. Janna C. Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neven, Patrick, Erika Hamilton, Barbara Pistilli, et al.. (2023). 206P Capivasertib (C) + palbociclib (P) and fulvestrant (F) in patients (pts) with HR+/HER2- advanced breast cancer (ABC): Phase Ib data from CAPItello-292. ESMO Open. 8(1). 101395–101395. 2 indexed citations
2.
Ryu, Young Hoon, Jeih‐San Liow, Sami S. Zoghbi, et al.. (2007). Disulfiram Inhibits Defluorination of 18F-FCWAY, Reduces Bone Radioactivity, and Enhances Visualization of Radioligand Binding to Serotonin 5-HT1A Receptors in Human Brain. Journal of Nuclear Medicine. 48(7). 1154–1161. 43 indexed citations
3.
Rosh, Joel R., Janna C. Collins, Gabriel M. Groisman, et al.. (1995). Management of Hepatic Adenoma in Glycogen Storage Disease Ia. Journal of Pediatric Gastroenterology and Nutrition. 20(2). 225–228. 6 indexed citations
4.
Rosh, Joel R., Janna C. Collins, Gabriel M. Groisman, et al.. (1995). Management of Hepatic Adenoma in Glycogen Storage Disease Ia. Journal of Pediatric Gastroenterology and Nutrition. 20(2). 225–228. 1 indexed citations
5.
Collins, Janna C.. (1993). Penicillamine (PCA) prophylaxis for asymptomatic children with Wilson's disease (WD). Hepatology. 18(4). A128–A128. 3 indexed citations
6.
Collins, Janna C., Douglas N. Buchanan, Jess G. Thoene, et al.. (1992). Metabolic studies in a mouse model of hepatorenal tyrosinemia: Absence of perinatal abnormalities. Biochemical and Biophysical Research Communications. 187(1). 338–346. 7 indexed citations
7.
Bout, A., et al.. (1991). Characterization of the gene encoding human peroxisomal 3-oxoacyl-CoA thiolase (ACAA). No large DNA rearrangement in a thiolase-deficient patient. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1090(1). 43–51. 28 indexed citations
8.
Clayton, Peter T., et al.. (1990). Bile acid profiles in peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency.. Journal of Clinical Investigation. 85(4). 1267–1273. 30 indexed citations
9.
Collins, Janna C. & Sidney Goldfischer. (1990). Perinatal Hemochromatosis: One Disease, Several Diseases or A Spectrum?. Hepatology. 12(1). 176–177. 21 indexed citations
10.
Collins, Janna C., et al.. (1989). Hepatic peroxisomal abnormalities in abetalipoproteinemia. Gastroenterology. 97(3). 766–770. 33 indexed citations
11.
Kaplan, Michael, et al.. (1988). Cerebrohepatorenal syndrome of Zellweger: a peroxisomal deficiency disorder. Case report and review.. PubMed. 24(6). 319–24. 1 indexed citations
12.
Collins, Janna C., Allan W. Wolkoff, Anatol G. Morell, & Richard J. Stockert. (1988). Selective regulation of intrinsic membrane proteins in HepG2. Hepatology. 8(1). 108–115. 11 indexed citations
13.
Chervu, L. Rao, et al.. (1988). Protein-Losing Enteropathy Detected by 99mTc-Labeled Human Serum Albumin Abdominal Scintigraphy. Journal of Pediatric Gastroenterology and Nutrition. 7(6). 872–876. 12 indexed citations
14.
Collins, Janna C., et al.. (1988). Biotin-dependent expression of the asialoglycoprotein receptor in HepG2.. Journal of Biological Chemistry. 263(23). 11280–11283. 56 indexed citations
15.
Schram, A. W., Sidney Goldfischer, C W van Roermund, et al.. (1987). Human peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency.. Proceedings of the National Academy of Sciences. 84(8). 2494–2496. 150 indexed citations
16.
Goldfischer, Sidney, Janna C. Collins, Isabelle Rapin, et al.. (1986). Pseudo-Zellweger syndrome: Deficiencies in several peroxisomal oxidative activities. The Journal of Pediatrics. 108(1). 25–32. 131 indexed citations
17.
Collins, Janna C., et al.. (1984). Hepatitis B Virus Infections Transmitted from Retarded Children to Their Families During Brief Home Exposure. Journal of Pediatric Gastroenterology and Nutrition. 3(1). 69–71. 5 indexed citations
18.
Stockert, Richard J., et al.. (1982). IgA interaction with the asialoglycoprotein receptor.. Proceedings of the National Academy of Sciences. 79(20). 6229–6231. 151 indexed citations
19.
Collins, Janna C., et al.. (1978). Bile acid synthesis in man III. Identification of 26-hydroxycholesterol in serum in zellweger syndrome. Gastroenterology. 75(5). 959–959. 3 indexed citations
20.
Collins, Janna C., et al.. (1962). Lymphosarcoma of the ovary; report of a case with review of the literature.. PubMed. 20. 686–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kayoko Sudo Breakdown of academic impact, for papers by Tomoyuki Yamasaki Breakdown of academic impact, for papers by D G Brocks Breakdown of academic impact, for papers by Yoji Shibayama Breakdown of academic impact, for papers by Esmeralda Martins Breakdown of academic impact, for papers by M F Melhem Breakdown of academic impact, for papers by Kunihiko Tatsumi Breakdown of academic impact, for papers by Elisa Oppici Breakdown of academic impact, for papers by Richard L. Boriack
Rankless by CCL
2026